Posters

    Screening Of Aqueous Media Using GC×GC-TOF-MS

    Almstetter, M.; Knorr, A.; Debrick , A.; Dutertre, Q.; Bentley, M.
    Conference date
    Sep 17, 2013
    Conference name

    European GCxGC Symposium 2013 International Conference of the Metabolomics Society 2013
    Link to more information
    Link to more information
    Topic
    Summary

    Comprehensive two-dimensional gas chromatography coupled to fast acquisition time-of-flight mass spectrometry (GC×GC-TOFMS) is a widely established method for non-targeted analyses. However, for tobacco and tobacco related research, the inherently complex chemical space usually requires the use of a number of different experimental strategies. The development and implementation of a non-targeted GC×GC-TOFMS approach for aqueous samples, e.g. cigarette smoke trapped in phosphate buffered saline (PBS) or microsomal incubation samples is described. The presented approach comprises minimal sample preparation for lowest risk of changing chemical constituent profiles and enables a broad coverage of volatile compounds without the need of using additional methods. Aqueous trapping solution is directly injected on-column and analyzed by GC×GC-TOFMS using a combination of water resistant ionic-liquid based analytical columns. By avoiding any solvent delay, this setup allows the detection of highly volatile furans amongst other constituents. A set of furans was used to test the reproducibility, linearity and robustness of the chromatographic separation. Non-targeted screening of complex matrices such as cigarette smoke trapped in aqueous media is also discussed. This method represents a novel approach, which defies the common belief that aqueous media are incompatible with gas chromatography.

    PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
    ​
    Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.